Viral Hepatitis A, B & C: Surveillance, Prevention & Control
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
NYS DOH Removes Hep C Med Restrictions in FFS Medicaid
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
-
Take Action! Support the Viral Hepatitis Testing Act
TAKE ACTION TO INCREASE SUPPORT FOR THIS IMPORTANT LEGISLATION!
-
ACP/CDC | Hep B Screening, Vaccination & Linkage to Care Recommendations
The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
-
Article | Hep C treatment turned me around: Psychological & Behavioral Transformation
Participants described psychological and behavioral transformation over the course of HCV treatment. These included reductions in internalized stigma and shame related to HCV and addiction, increases in HCV disclosure and self-care, reductions in substance use, and new desire to ...
-
NYC Health Department Announces Strategic Plan to Combat Hepatitis C
The NYC Health Department today released the City's first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS
-
CDC Advisory Committee on Immunization Practices to Recommend Universal Hep B Vaccination
Historic vote by CDC’s Advisory Committee on Immunization Practices (ACIP) to Recommend Universal Hep B Vaccination.
-
NYS 2020 Viral Hepatitis Strategic Plan (NYS DOH)
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
-
Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries
Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illi...
